English
简体中文
Total: £ 56.28
2026-01-30 | Pages: 108 | Tables: 116
The global Cannabis Pharmaceuticals market was valued at US$ 1483 million in 2025 and is anticipated to reach US$ 3621 million by 2032, at a CAGR of 13.8% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global ...
2026-01-30 | Pages: 113 | Tables: 114
The global Elderberry Supplements market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscap...
2026-01-30 | Pages: 126 | Tables: 121
The global Immunosuppressive Therapy for Eye Diseases market was valued at US$ 4924 million in 2025 and is anticipated to reach US$ 7962 million by 2032, at a CAGR of 7.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty...
2026-01-30 | Pages: 131 | Tables: 132
The global Ocular Immunosuppressants market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lands...
2026-01-30 | Pages: 123 | Tables: 121
The global Immunosuppressive Drugs for Ocular Inflammation market was valued at US$ 4924 million in 2025 and is anticipated to reach US$ 7962 million by 2032, at a CAGR of 7.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncert...
2026-01-30 | Pages: 127 | Tables: 121
The global Ocular Immunosuppresent market was valued at US$ 4924 million in 2025 and is anticipated to reach US$ 7962 million by 2032, at a CAGR of 7.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global ec...
2026-01-30 | Pages: 135 | Tables: 128
The global Synthetic Hemostatic and Wound Care Products market was valued at US$ 4834 million in 2025 and is anticipated to reach US$ 7055 million by 2032, at a CAGR of 5.6% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertain...
2026-01-30 | Pages: 151 | Tables: 152
The global Pharmaceutical Grade Melatonin Products market was valued at US$ 1192 million in 2025 and is anticipated to reach US$ 1865 million by 2032, at a CAGR of 6.7% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty in...
2026-01-30 | Pages: 98 | Tables: 107
The global Rotavirus Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. Th...
2026-01-30 | Pages: 101 | Tables: 98
The global Multivalent Oral Rotavirus Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
2026-01-30 | Pages: 133 | Tables: 132
The global Cas9 Nuclease market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This r...
2026-01-30 | Pages: 121 | Tables: 125
The global Cas12 Nuclease market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This ...
2026-01-30 | Pages: 126 | Tables: 126
The global Coccidiosis Vaccines market was valued at US$ 176 million in 2025 and is anticipated to reach US$ 244 million by 2032, at a CAGR of 4.8% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-01-30 | Pages: 121 | Tables: 124
The global Coccidiosis Vaccines in Chickens market was valued at US$ 192 million in 2025 and is anticipated to reach US$ 293 million by 2032, at a CAGR of 6.3% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the gl...
2026-01-30 | Pages: 116 | Tables: 111
The global Risedronate Sodium Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
